Cybin Inc. (OTCMKTS:CLXPF - Get Free Report)'s stock price rose 5.9% during trading on Thursday . The company traded as high as $6.43 and last traded at $6.26. Approximately 293,158 shares traded hands during mid-day trading, a decline of 47% from the average daily volume of 551,962 shares. The stock had previously closed at $5.91.
Cybin Stock Down 9.5 %
The company has a market capitalization of $765.28 million and a P/E ratio of -21.46. The business has a 50 day moving average of $8.01 and a 200 day moving average of $9.28.
Cybin Company Profile
(
Get Free Report)
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Articles
Before you consider Cybin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cybin wasn't on the list.
While Cybin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
